Dual 5-alpha reductase inhibitor API in powder form for capsule manufacturing by prostate health drug companies. Distributed to wholesalers and compounding facilities serving urologists and endocrinologists in treating benign prostatic hyperplasia within the pharmaceutical and medical device industries.